Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Wasima Rida

3PUBLICATIONS

1CO-AUTHORS

Haematological tumoursEpidemiological methodsInnate immunity

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Dec 08, 2025

Humoral and functional SARS-CoV-2-specific T-cell responses elicited in chronic lymphocytic leukaemia patients with GEO-CM04S1 a synthetic MVA-vectored COVID-19 vaccine.

Sandra Ortega-Francisco, Maria Teresa Prudente de Aquino, Corinna La Rosa

|Jun 21, 2016

Efficacy and Safety of 'Fixed Dose' versus 'Loose' Drug Regimens for Treatment of Pulmonary Tuberculosis in Two High TB-Burden African Countries: A Randomized Controlled Trial.

Abraham Aseffa, Joseph N Chukwu, Mahnaz Vahedi

|Apr 13, 2016

T-cell activation is an immune correlate of risk in BCG vaccinated infants.

Helen A Fletcher, Margaret A Snowden, Bernard Landry

Pageof 1

Frequent Collaborators

1 joint publications

Cathy Connolly

Frequent Collaborators

1 joint publications

Cathy Connolly

Top Related Videos

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on : May 27, 2011

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged <em>Mycobacterium tuberculosis</em>

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged <em>Mycobacterium tuberculosis</em>

Published on : Mar 24, 2017

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on : Sep 19, 2016

See more related videos

Top Related Videos

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on : May 27, 2011

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged <em>Mycobacterium tuberculosis</em>

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged <em>Mycobacterium tuberculosis</em>

Published on : Mar 24, 2017

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on : Sep 19, 2016

See more related videos